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After a historical period in which clinical microbiology
laboratories (CMLs) constituted only a subset of clinical
chemistry laboratories (CCLs), CMLs were individualized, and
their organization mirrored the ‘Pasteur model,’ based on
overnight incubation and reading in the daytime, with natural
lighting for adequate plate reading. Outside of open hours, the
panel of microbiology services was generally limited to blood
culture (BC) loading into BC instruments (BCIs), the direct
examination of cerebrospinal ﬂuid, and, in certain cases, plate
inoculation with a limited number of precious samples. In this
model, CMLs and emergency laboratories were commonly
physically disconnected, and, very often, the microbiology
emergency laboratory was located within a 24/7 CCL and
serviced by the CCL laboratory technicians (LTs).
Interestingly, the continuous reading of BCs with BCIs,
combined with evidence that early diagnosis and management
of sepsis reduced mortality, encouraged many laboratories to
implement continuous processing of positive BCs [1]. To this
end, the emergency bench dedicated to microbiological
testing, although still located within the 24/7 CCLs, began to
be serviced by LTs with expertise in microbiology. Automation
was progressively introduced to perform Gram staining, urine
sample cytometry, and fully automated PCR, requiring increas-
ingly large emergency microbiological laboratories [2] to
process an increasing number of samples.
Whereas CCLs became fully automated, automation in
CMLs was limited to BCIs, biochemical identiﬁcation, and
antibiotic susceptibility testing [2]. Several recent consider-
ations resulted in the total automation (TA) of CMLs: (i) the
merging of CMLs, owing to reductions in public health budgets,
allowing an increase in the number of samples of similar types
[3]; (ii) the introduction of liquid-based swab transport
devices, allowing automation for a larger number of samples
and less restrictive sample transport; and (iii) a high-traceability
requirement, owing to international standards for quality
management. By shifting the CML from manual processes to
‘computer-assisted bacteriology’, TA, together with the
implementation of lean management theory and the Toyota
Production System previously used in CCLs [4], has the
potential to reduce both the time to obtain results (TTR)
and human resources costs, while increasing economic
efﬁciency [5].
The model involves a centralized core laboratory linked
to one or more 24/7 point-of-care (POC) laboratories
located in each hospital, within or near emergency and
intensive-care units. POC laboratories are designed as
autonomous structures requiring minimal dedicated material
and reagents, and relying on immunological assays or fully
automatic molecular tests [6]. POC laboratories decrease
the length of stay of infected patients with enterovirus
meningitis, and impact on patient management [6]. However,
POC laboratories are limited by their panels of analyses, by
the performance of their tests, needing conﬁrmation with
second-line tests in the core laboratory and thus impairing
the global cost-effectiveness, and by the need for early
processing or convenient storage of samples requiring
conventional culture for diagnosis. Whereas core laborato-
ries are currently evolving towards TA, they are not
necessarily moving towards 24/7 organization, thanks to
24/7 POC laboratories. Thus, core laboratories do not
beneﬁt from the potential 24/7 sample processing provided
by fully automated instruments.
The future model: a 24/7 CML Single
Platform Combining Automation and
Molecular Tests
This model is based on merging the completely automated
CML and the 24/7 laboratory into a uniﬁed, 24/7, fully
automated laboratory resembling current CCLs. The spatial
organization of such a laboratory will be challenging, because
it needs to achieve an optimal workﬂow both during the
daytime, when it is serviced by a large number of people, and
at night and on holidays, when only a few people will be in
charge of the microbiology laboratory, with the need to have
access to many different instruments. These instruments
include BCIs, automatic inoculators/incubators, PCR instru-
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ments, safety cabinets for pre-analytical processing, cytome-
ters, microscopes, and Gram stainers. All of these instru-
ments and the work areas should be interconnected in a lean
manner for both rush hour and off-peak times, which is a
challenge. Thanks to TA, a large number of tasks can be
performed by a reduced number of LTs, allowing continuous
processing of positive samples and a reduction in TTR, which
is associated with improved clinical outcomes and reductions
in the length of hospitalization and health-associated costs [7].
Whereas the direct identiﬁcation of positive BCs by
matrix-assisted laser desorption ionization time-of-ﬂight mass
spectrometry leads to a reduction in the TTR and to a clinical
impact on therapy and patient intake [8], a 24/7, completely
automated CML would extend these gains to a larger number
of samples and most likely would help to optimize antibiotic
therapies. However, this model requires efﬁcient sample
transport by pneumatic systems or ground transportation,
achieving overall management of a sample in <2 h following
sampling. If these conditions are met, an on-site POC system
could be restricted to doctor tests conducted by physicians
or nurses and to a few fully automated tests under CML
control.
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